FDA Inspection 1325046 — Musculoskeletal Transplant Foundation

Musculoskeletal Transplant Foundation — FEI 3000718045

The FDA completed an inspection of Musculoskeletal Transplant Foundation on Jun 25, 2026 in Syracuse, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 25, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Syracuse, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.